MELISSA ANDERSEN: Open Payments
NPI 1194464909 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 37 payments from 7 companies in 2025. Trend: 2023 $443 · 2024 $750 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $143 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| CVRx, Inc. | 4 | $45 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: LEQVIO, VERQUVO, Barostim Neo System, ENTRESTO, FUROSCIX, JARDIANCE, WAINUA, NEXLETOL.
Industry payments across NY — which companies pay providers there.
